Ophthalmology

Articles filed under Ophthalmology.

• Review of nepafenac (Nevanac) ophtalmic suspension

  January 5, 2009

  Review form Health Canada of nepafenac (Nevanac) , a non-steroidal anti-inflammatory drug (NSAID) for the management of pain and inflammation associated with cataract surgery On April 17, 2008, Health Canada issued a Notice of Compliance to Alcon Canada Inc. for the drug product, NevanacTM (nepafenac) Ophthalmic Suspension. NevanacTM contains the medicinal ingredient nepafenac which is

• Off-label intravitreal use of bevacizumab (Avastin): reports of ocular side effects

  January 2, 2009

  Letter from Roche to health care professionals dated December 16, 2008. Related to off- label uses in ophtalmology of bevacizumab (Avastin): Reports of Eye Inflammation, Endophthalmitis, and Toxic Anterior Segment Syndrome (TASS) Following Off-label Intravitreal Use of AVASTIN® (bevacizumab)